- $17.74m
- $17.35m
- $1.68m
2019 September 30th | 2020 September 30th | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.37 | 0.946 | 0.219 | 0.164 | 1.68 |
Cost of Revenue | |||||
Gross Profit | 0.37 | — | — | -0.297 | 0.79 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.9 | 0.874 | 3.09 | 20.4 | 12.7 |
Operating Profit | -0.53 | 0.073 | -2.87 | -20.3 | -11 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.53 | 0.073 | -2.74 | -21.5 | -12.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.53 | 0.073 | -2.74 | -21.5 | -12.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.53 | 0.073 | -2.74 | -21.5 | -12.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.3 | 0.073 | -2.74 | -21.5 | -12.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.019 | 0.004 | -0.145 | -0.264 | -0.144 |